Tag: ivermectin cancer treatment

Categories
All Family Health Anti Cancer Cancer Treatment Cancer Treatment & Outcomes Cancer Treatment Guidance Cancer Treatment Options Cancer Wellness Protocols Drug Repurposing & Innovation Fenbendazole Fenbendazole and Cancer Health & Wellness integrative-oncology Ivermectin Mebendazole Non-Chemo Cancer Treatments Pillar Repurposed Drugs and Cancer Research

CAC Announces New Relationship with All Family Health

Courage Against cancer and All Family Health partner for better outcomes

Courage Against Cancer is excited to announce a new relationship with All Family Health, expanding access to convenient telehealth consultations with licensed healthcare providers. Through this new resource, individuals can request medical evaluations for prescription medications including ivermectin and mebendazole, when clinically appropriate. CAC does not prescribe or determine treatment—we connect our community with additional healthcare resources so patients can have informed conversations with qualified medical professionals about their options.

Categories
Anti Cancer Cancer Research & Clinical Evidence Cancer Treatment Cancer Treatment Guidance Colorectal Cancer Treatment & Research Drug Repurposing & Innovation Evaluating Cancer Treatment Claims Fenbendazole Health & Wellness Ivermectin Mebendazole Mitochondria Non-Chemo Cancer Treatments Repurposed Drugs and Cancer Research

How does fenbendazole differ from other repurposed drugs like metformin or ivermectin in colorectal cancer research?

Fenbendazole compared to metformin and ivermectin in colorectal cancer research - featured image

Fenbendazole, metformin, and ivermectin target colorectal cancer through different mechanisms. Fenbendazole disrupts tubulin, metformin inhibits energy production, and ivermectin blocks drug resistance. While metformin has the strongest human evidence, none have FDA approval for cancer treatment. Ongoing research is needed, and patients should consult their oncology teams for guidance.

Categories
Anti Cancer Cancer Research & Clinical Evidence Cancer Support & Encouragement Cancer Treatment & Clinical Research Cancer Treatment & Outcomes Cancer Treatment Claims & Critical Analysis Cancer Treatment Options Cancer Treatment Research & Critical Analysis Cancer Wellness Protocols Colorectal Cancer Drug Repurposing & Innovation Evaluating Cancer Treatment Claims Fenbendazole Health & Wellness Hulscher Study Integrative Oncology Insights Ivermectin Mebendazole Natural Treatments Non-Chemo Cancer Treatments Pancreatic Cancer Repurposed Drug Studies Research News & Updates

What Oncologists and Evidence-Based Medicine Say About Ivermectin for Cancer Right Now

What science says about iveremctin and cancer

Courage Against Cancer clarifies that ivermectin lacks validated clinical evidence as a cancer treatment despite preclinical interest. Major oncology institutions do not endorse it, emphasizing the importance of rigorous evidence-based evaluations. Patients are encouraged to discuss concerns with their oncologists and critically assess claims surrounding off-label treatments.

Categories
Anti Cancer Breakthrough Therapies Cancer Research & Clinical Evidence Cancer Support & Encouragement Cancer Treatment & Clinical Research Cancer Treatment Claims & Critical Analysis Cancer Treatment Research & Critical Analysis Cancer Wellness Protocols Colorectal Cancer Critical Evaluation of Cancer Research Drug Repurposing & Innovation Evaluating Cancer Treatment Claims Fenbendazole Gut Biome Gut-Microiome Health & Wellness Hulscher Study Integrative Oncology Insights Mebendazole Microbiome Non-Chemo Cancer Treatments Pancreatic Cancer Repurposed Drug Studies Research & Science Research News & Updates Wellness Company

What Is the Best Cancer Treatment for My Type and Stage of Cancer?

What Is the Best Cancer Treatment for My Type and Stage of Cancer

Courage Against Cancer emphasizes the importance of personalized cancer treatment plans, tailored based on cancer type, stage, and individual patient factors. This guide details various treatment modalities, including chemotherapy, radiation, immunotherapy, hormone therapy, and stem cell transplants, while encouraging patients to engage with their healthcare teams for informed decisions.

Categories
Anti Cancer Cancer Support & Encouragement Cancer Treatment & Clinical Research Cancer Treatment Claims & Critical Analysis Cancer Treatment Options Cancer Wellness Protocols Clinical Trials & Cancer Treatment Drug Repurposing & Innovation Evaluating Cancer Treatment Claims Health & Wellness Hulscher Study Ivermectin Mebendazole Non-Chemo Cancer Treatments Repurposed Drug Studies Research & Science Wellness Company

The Wellness Company Study of Ivermectin and Mebendazole Review

Hulscher cohort study of Ivermectin and Mebendazole

A study conducted by Dr. Nicolas Hulscher at the Wellness Company examined the effects of compounded Ivermectin and Menebedazole on 197 cancer patients over six months. While results appear promising, concerns arise regarding the study’s methodology, raising questions about the necessity of formal clinical trials for FDA consideration.

Categories
Anti Cancer cancer research Cancer Support & Encouragement Cancer Treatment Cancer Treatment & Clinical Research Cancer Treatment & Outcomes Cancer Treatment Claims & Critical Analysis Cancer Treatment Guidance Cluster Critical Evaluation of Cancer Research Drug Repurposing & Innovation Evaluating Cancer Treatment Claims Health & Wellness Hulscher Study Ivermectin Mebendazole

What is an ‘expression of concern’ from a scientific Hulscher 2026 ivermectin study financially connected to The Wellness Company?

An expression of concern (EOC) is a warning from a journal about potential issues in a study’s integrity without retracting it. Anticancer Research issued an EOC for Hulscher et al. (2026), citing data verifiability and ethical concerns, particularly due to conflicts of interest and reliance on self-reported outcomes without rigorous controls.

Categories
Anti Cancer cancer research Cancer Support & Encouragement Cancer Treatment & Clinical Research Cancer Treatment & Outcomes Cancer Treratments Cancer Wellness Protocols Community Impact Critical Evaluation of Cancer Research Drug Repurposing & Innovation Evaluating Cancer Treatment Claims Fenbendazole Health & Wellness Hulscher Study Integrative Oncology Insights Ivermectin Mebendazole Non-Chemo Cancer Treatments preclinical trial Research & Science

Why did Anticancer Research publish an expression of concern about the 2026 ivermectin study on June 1, 2026?

On June 1, 2026, Anticancer Research issued an Expression of Concern regarding Hulscher et al.’s study on ivermectin-mebendazole, citing issues with data verifiability, statistical reliability, and ethical oversight. The study’s self-reported outcomes and lack of independent monitoring raised further doubts, necessitating independent scrutiny before clinical application.

Categories
Anti Cancer cancer research Cancer Treratments drug repurposing integrative-oncology Ivermectin Mebendazole Mission & Vision preclinical trial Repurposed Drug Studies Research & Science

Combining Ivermectin & Mebendazole with Standard Cancer Therapies: Exploring Potential Synergies in the Fight Against Cancer

Jake shows his courage exploring Ivermectin and Mebendazole
yep

Courage Against Cancer explores how ivermectin and mebendazole — two promising repurposed drugs — may enhance the effectiveness of standard cancer treatments. Learn how our ovarian cancer preclinical study aims to uncover synergistic potential that could redefine the future of integrative oncology.